Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) CEO Anthony Hayes acquired 3,944 shares of the firm’s stock in a transaction on Thursday, April 4th. The stock was bought at an average price of $2.62 per share, with a total value of $10,333.28. Following the purchase, the chief executive officer now directly owns 102,748 shares of the company’s stock, valued at $269,199.76. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Dominari Price Performance
NASDAQ DOMH opened at $2.87 on Thursday. Dominari Holdings Inc. has a 1 year low of $1.76 and a 1 year high of $3.76. The company has a market capitalization of $17.02 million, a PE ratio of -0.65 and a beta of 0.91. The company has a fifty day moving average of $2.27 and a two-hundred day moving average of $2.22.
Hedge Funds Weigh In On Dominari
Several large investors have recently bought and sold shares of the stock. Citadel Advisors LLC acquired a new position in Dominari in the second quarter valued at $52,000. State Street Corp acquired a new position in Dominari in the second quarter valued at $58,000. Renaissance Technologies LLC acquired a new stake in shares of Dominari during the second quarter worth about $109,000. BlackRock Inc. acquired a new stake in shares of Dominari during the second quarter worth about $219,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Dominari during the second quarter worth about $126,000. Institutional investors and hedge funds own 42.48% of the company’s stock.
Dominari Company Profile
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Recommended Stories
- Five stocks we like better than Dominari
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
- How to Capture the Benefits of Dividend Increases
- WD-40 Company Greases the Wheels of Growth and Profits
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- How to Protect your Portfolio Against a Rising VIX
Receive News & Ratings for Dominari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dominari and related companies with MarketBeat.com's FREE daily email newsletter.
